Search Within

Kinga Hosszu

Formats
  1. Meeting Abstract (29)
  2. Journal Article (13)
  3. Review (3)
  4. Research Letter (1)
Groups
  1. Pediatrics, Department of (46)
  2. Center for Hematologic Malignancies (37)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (34)
  5. Bone Marrow Transplant (26)
  6. Hematology-Oncology Fellows (24)

More Groups

People
  1. Devin Mcavoy (36)
  2. Jaap Jan Boelens (21)
  3. Gunjan Shah (18)
  4. Sergio Giralt (18)
  5. Michael Scordo (17)
  6. Alexander Lesokhin (14)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (2)
Publications
  1. Blood (13)
  2. Cytotherapy (10)
  3. Clinical Lymphoma, Myeloma and Leukemia (4)
  4. Bone Marrow Transplantation (3)
  5. Blood Advances (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Science Ltd. (10)
  3. Elsevier Inc. (7)
  4. Nature Publishing Group (4)
  5. American Society of Clinical Oncology (2)
  6. Frontiers Media S.A. (2)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
    Journal Article

    Andrlová, H.; Miltiadous, O.; Kousa, A. I.; Dai, A.; DeWolf, S.; Violante, S.; Park, H. Y.; Janaki-Raman, S.; Gardner, R.; El Daker, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • SLE: Novel postulates for therapeutic options
    Review

    Hosszu, K. K.; Valentino, A.; Peerschke, E. I.; Ghebrehiwet, B.
    Frontiers in Immunology (2020)

    Fulltext@MSK | Save
  • Immune monitoring after allogeneic hematopoietic cell transplantation: Toward practical guidelines and standardization
    Review

    Boelens, J. J.; Hosszu, K. K.; Nierkens, S.
    Frontiers in Pediatrics (2020)

    Fulltext@MSK | Save